Breast Cancer Res Volume 7(6); 2005

Kathleen Conway, Eloise Parrish, Sharon N Edmiston, Dawn Tolbert, Chiu-Kit Tse, Joseph Geradts, Chad A Livasy, Harsharan Singh, Beth Newman, Robert C Millikan

Breast Cancer Res. 2005; 7(6): R871–R880. Published online 2005 September 6. doi: 10.1186/bcr1315

PMCID:: PMC1410768

Abstract Full Text PDF–211K

Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ

Ruria Namba, Lawrence JT Young, Jeannie E Maglione, Erik T McGoldrick, Stephenie Liu, Gregory T Wurz, Michael W DeGregorio, Alexander D Borowsky, Carol L MacLeod, Robert D Cardiff, Jeffrey P Gregg

Breast Cancer Res. 2005; 7(6): R881–R889. Published online 2005 September 13. doi: 10.1186/bcr1317

PMCID:: PMC1410776

Abstract Full Text PDF–733K

CYP17 gene polymorphism in relation to breast cancer risk: a case-control study

Kristjana Einarsdóttir, Tove Rylander-Rudqvist, Keith Humphreys, Susanne Ahlberg, Gudrun Jonasdottir, Elisabete Weiderpass, Kee Seng Chia, Magnus Ingelman-Sundberg, Ingemar Persson, Jianjun Liu, Per Hall, Sara Wedrén

Breast Cancer Res. 2005; 7(6): R890–R896. Published online 2005 September 14. doi: 10.1186/bcr1319

PMCID:: PMC1410739

Abstract Full Text PDF–170K Supplementary Material

Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells

Kenyon G Daniel, Di Chen, Shirley Orlu, Qiuzhi Cindy Cui, Fred R Miller, Q Ping Dou

Breast Cancer Res. 2005; 7(6): R897–R908. Published online 2005 September 20. doi: 10.1186/bcr1322

PMCID:: PMC1410741

Abstract Full Text PDF–1.0M Supplementary Material

Genetic polymorphisms in human SULT1A1 and UGT1A1 genes associate with breast tumor characteristics: a case-series study

Ekaterina G Shatalova, Susan E Walther, Olga O Favorova, Timothy R Rebbeck, Rebecca L Blanchard

Breast Cancer Res. 2005; 7(6): R909–R921. Published online 2005 September 21. doi: 10.1186/bcr1318

PMCID:: PMC1410736

Abstract Full Text PDF–321K

Positive association between mammographic breast density and bone mineral density in the Postmenopausal Estrogen/Progestin Interventions Study

Carolyn Crandall, Shana Palla, Beth A Reboussin, Giske Ursin, Gail A Greendale

Breast Cancer Res. 2005; 7(6): R922–R928. Published online 2005 September 22. doi: 10.1186/bcr1327

PMCID:: PMC1410758

Abstract Full Text PDF–328K

Evolutionary conservation analysis increases the colocalization of predicted exonic splicing enhancers in the BRCA1 gene with missense sequence changes and in-frame deletions, but not polymorphisms

Christopher Pettigrew, Nicola Wayte, Paul K Lovelock, Sean V Tavtigian, Georgia Chenevix-Trench, Amanda B Spurdle, Melissa A Brown

Breast Cancer Res. 2005; 7(6): R929–R939. Published online 2005 September 22. doi: 10.1186/bcr1324

PMCID:: PMC1410749

Abstract Full Text PDF–305K

Targeted therapy against Bcl-2-related proteins in breast cancer cells

Manabu Emi, Ryungsa Kim, Kazuaki Tanabe, Yoko Uchida, Tetsuya Toge

Breast Cancer Res. 2005; 7(6): R940–R952. Published online 2005 September 28. doi: 10.1186/bcr1323

PMCID:: PMC1410745

Abstract Full Text PDF–1.0M

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts

Yudi Pawitan, Judith Bjöhle, Lukas Amler, Anna-Lena Borg, Suzanne Egyhazi, Per Hall, Xia Han, Lars Holmberg, Fei Huang, Sigrid Klaar, Edison T Liu, Lance Miller, Hans Nordgren, Alexander Ploner, Kerstin Sandelin, Peter M Shaw, Johanna Smeds, Lambert Skoog, Sara Wedrén, Jonas Bergh

Breast Cancer Res. 2005; 7(6): R953–R964. Published online 2005 October 3. doi: 10.1186/bcr1325

PMCID:: PMC1410752

Abstract Full Text PDF–1.4M Supplementary Material

Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells

Paige J Baugher, Lakshmi Krishnamoorthy, Janet E Price, Surangani F Dharmawardhane

Breast Cancer Res. 2005; 7(6): R965–R974. Published online 2005 September 30. doi: 10.1186/bcr1329

PMCID:: PMC1410764

Abstract Full Text PDF–611K

Quantification of the response of circulating epithelial cells to neodadjuvant treatment for breast cancer: a new tool for therapy monitoring

Katharina Pachmann, Oumar Camara, Andreas Kavallaris, Uwe Schneider, Stefanie Schünemann, Klaus Höffken

Breast Cancer Res. 2005; 7(6): R975–R979. Published online 2005 October 4. doi: 10.1186/bcr1328

PMCID:: PMC1410761

Abstract Full Text PDF–425K

25-Hydroxyvitamin D₃1α-hydroxylase expression in breast cancer and use of non-1α-hydroxylated vitamin D analogue

Ulrika Segersten, Pernille Kaae Holm, Peyman Björklund, Ola Hessman, Hans Nordgren, Lise Binderup, Göran Åkerström, Per Hellman, Gunnar Westin

Breast Cancer Res. 2005; 7(6): R980–R986. Published online 2005 October 6. doi: 10.1186/bcr1332

PMCID:: PMC1410765

Abstract Full Text PDF–544K

XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study

Katja Metsola, Vesa Kataja, Pia Sillanpää, Päivi Siivola, Liisa Heikinheimo, Matti Eskelinen, Veli-Matti Kosma, Matti Uusitupa, Ari Hirvonen

Breast Cancer Res. 2005; 7(6): R987–R997. Published online 2005 October 11. doi: 10.1186/bcr1333

PMCID:: PMC1410770

Abstract Full Text PDF–227K

Expression analysis of candidate breast tumour suppressor genes on chromosome 16q

Tom van Wezel, Marcel Lombaerts, Eddy H van Roon, Katja Philippo, Hans J Baelde, Karoly Szuhai, Cees J Cornelisse, Anne-Marie Cleton-Jansen

Breast Cancer Res. 2005; 7(6): R998–R1004. Published online 2005 October 18. doi: 10.1186/bcr1337

PMCID:: PMC1410740

Abstract Full Text PDF–365K

Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer

Aaron G Lewis, James Flanagan, Anna Marsh, Gulietta M Pupo, Graham Mann, Amanda B Spurdle, Geoffrey J Lindeman, Jane E Visvader, Melissa A Brown, Georgia Chenevix-Trench, the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer

Breast Cancer Res. 2005; 7(6): R1005–R1016. Published online 2005 October 21. doi: 10.1186/bcr1336

PMCID:: PMC1410737

Abstract Full Text PDF–189K

Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer

Susan A Higgins, Ellen T Matloff, David L Rimm, James Dziura, Bruce G Haffty, Bonnie L King

Breast Cancer Res. 2005; 7(6): R1017–R1022. Published online 2005 October 24. doi: 10.1186/bcr1335

PMCID:: PMC1410733

Abstract Full Text PDF–144K

A common missense variant in BRCA2 predisposes to early onset breast cancer

Bohdan Górski, Steven A Narod, Jan Lubiński

Breast Cancer Res. 2005; 7(6): R1023–R1027. Published online 2005 October 24. doi: 10.1186/bcr1338

PMCID:: PMC1410744

Abstract Full Text PDF–112K

Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis

Jorge S Reis-Filho, Fernanda Milanezi, Silvia Carvalho, Pete T Simpson, Dawn Steele, Kay Savage, Maryou BK Lambros, Emilio M Pereira, Jahn M Nesland, Sunil R Lakhani, Fernando C Schmitt

Breast Cancer Res. 2005; 7(6): R1028–R1035. Published online 2005 October 25. doi: 10.1186/bcr1341

PMCID:: PMC1410747

Abstract Full Text PDF–1.1M

The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells

Radhika P Ghatge, Britta M Jacobsen, Stephanie A Schittone, Kathryn B Horwitz

Breast Cancer Res. 2005; 7(6): R1036–R1050. Published online 2005 November 2. doi: 10.1186/bcr1340

PMCID:: PMC1410743

Abstract Full Text PDF–1.2M Supplementary Material

Allelic imbalances of chromosomes 8p and 18q and their roles in distant relapse of early stage, node-negative breast cancer

Aki Morikawa, Tanisha Y Williams, Luc Dirix, Cecile Colpaert, Michael Goodman, Robert H Lyles, Diansheng Zhong, Wei Zhou

Breast Cancer Res. 2005; 7(6): R1051–R1057. Published online 2005 November 2. doi: 10.1186/bcr1349

PMCID:: PMC1410773

Abstract Full Text PDF–171K

HER-2 overexpression differentially alters transforming growth factor-β responses in luminal versus mesenchymal human breast cancer cells

Cindy A Wilson, Elaina E Cajulis, Jennifer L Green, Taylor M Olsen, Young Ah Chung, Michael A Damore, Judy Dering, Frank J Calzone, Dennis J Slamon

Breast Cancer Res. 2005; 7(6): R1058–R1079. Published online 2005 November 8. doi: 10.1186/bcr1343

PMCID:: PMC1410754

Abstract Full Text PDF–1.4M Supplementary Material

Inhibition of CCN6 (WISP3) expression promotes neoplastic progression and enhances the effects of insulin-like growth factor-1 on breast epithelial cells

Yanhong Zhang, Quintin Pan, Hui Zhong, Sofia D Merajver, Celina G Kleer

Breast Cancer Res. 2005; 7(6): R1080–R1089. Published online 2005 November 8. doi: 10.1186/bcr1351

PMCID:: PMC1410771

Abstract Full Text PDF–1.1M

Breast cancer histological classification: agreement between the Office for National Statistics and the National Health Service Breast Screening Programme

Toral Gathani, Diana Bull, Jane Green, Gillian Reeves, Valerie Beral,

Breast Cancer Res. 2005; 7(6): R1090–R1096. Published online 2005 November 9. doi: 10.1186/bcr1352

PMCID:: PMC1410775

Abstract Full Text PDF–104K

Effects of combined treatment with rapamycin and cotylenin A, a novel differentiation-inducing agent, on human breast carcinoma MCF-7 cells and xenografts

Takashi Kasukabe, Junko Okabe-Kado, Nobuo Kato, Takeshi Sassa, Yoshio Honma

Breast Cancer Res. 2005; 7(6): R1097–R1110. Published online 2005 November 9. doi: 10.1186/bcr1344

PMCID:: PMC1410757

Abstract Full Text PDF–1.0M

Antisense oligonucleotides targeting the progesterone receptor inhibit hormone-independent breast cancer growth in mice

Caroline A Lamb, Luisa A Helguero, Sebastián Giulianelli, Rocío Soldati, Silvia I Vanzulli, Alfredo Molinolo, Claudia Lanari

Breast Cancer Res. 2005; 7(6): R1111–R1121. Published online 2005 November 9. doi: 10.1186/bcr1345

PMCID:: PMC1410760

Abstract Full Text PDF–1.0M

Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation

Gillian Mitchell, Yoland C Antill, William Murray, Judy Kirk, Elizabeth Salisbury, Geoffrey J Lindeman, Juliana Di Iulio, Alvin D Milner, Lisa Devereaux, Kelly-Anne Phillips

Breast Cancer Res. 2005; 7(6): R1122–R1131. Published online 2005 November 14. doi: 10.1186/bcr1348

PMCID:: PMC1410769

Abstract Full Text PDF–347K

Dehydroepiandrosterone inhibits the progression phase of mammary carcinogenesis by inducing cellular senescence via a p16-dependent but p53-independent mechanism

Anne Shilkaitis, Albert Green, Vasu Punj, Vernon Steele, Ronald Lubet, Konstantin Christov

Breast Cancer Res. 2005; 7(6): R1132–R1140. Published online 2005 November 16. doi: 10.1186/bcr1350

PMCID:: PMC1410767

Abstract Full Text PDF–617K

Preclinical evaluation of transcriptional targeting strategies for carcinoma of the breast in a tissue slice model system

Mariam A Stoff-Khalili, Alexander Stoff, Angel A Rivera, Nilam S Banerjee, Maaike Everts, Scott Young, Gene P Siegal, Dirk F Richter, Minghui Wang, Peter Dall, J Michael Mathis, Zeng B Zhu, David T Curiel

Breast Cancer Res. 2005; 7(6): R1141–R1152. Published online 2005 November 16. doi: 10.1186/bcr1353

PMCID:: PMC1410735

Abstract Full Text PDF–452K

Tamoxifen may prevent both ER+ and ER- breast cancers and select for ER- carcinogenesis: an alternative hypothesis

Laura J Esserman, Elissa M Ozanne, Mitch Dowsett, Joyce M Slingerland

Breast Cancer Res. 2005; 7(6): R1153–R1158. Published online 2005 November 21. doi: 10.1186/bcr1342

PMCID:: PMC1410777

Abstract Full Text PDF–132K

Farnesyl-transferase inhibitor R115,777 enhances tamoxifen inhibition of MCF-7 cell growth through estrogen receptor dependent and independent pathways

Florence Dalenc, Claire Giamarchi, Mélissa Petit, Marc Poirot, Gilles Favre, Jean-Charles Faye

Breast Cancer Res. 2005; 7(6): R1159–R1167. Published online 2005 November 21. doi: 10.1186/bcr1357

PMCID:: PMC1410750

Abstract Full Text PDF–542K

A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk

Alpa V Patel, Eugenia E Calle, Alexandre L Pavluck, Heather Spencer Feigelson, Michael J Thun, Carmen Rodriguez

Breast Cancer Res. 2005; 7(6): R1168–R1173. Published online 2005 November 21. doi: 10.1186/bcr1355

PMCID:: PMC1410742

Abstract Full Text PDF–134K

Prognostic relevance of disseminated tumor cells in the bone marrow and biological factors of 265 primary breast carcinomas

Christian Schindlbeck, Theresa Kampik, Wolfgang Janni, Brigitte Rack, Udo Jeschke, Stan Krajewski, Harald Sommer, Klaus Friese

Breast Cancer Res. 2005; 7(6): R1174–R1185. Published online 2005 November 24. doi: 10.1186/bcr1360

PMCID:: PMC1410751

Abstract Full Text PDF–223K

High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization

Tara L Naylor, Joel Greshock, Yan Wang, Theresa Colligon, QC Yu, Virginia Clemmer, Tal Z Zaks, Barbara L Weber

Breast Cancer Res. 2005; 7(6): R1186–R1198. Published online 2005 November 24. doi: 10.1186/bcr1356

PMCID:: PMC1410746

Abstract Full Text PDF–1.2M Supplementary Material

Reviews

Key stages in mammary gland development: The mammary end bud as a motile organ

Lindsay Hinck, Gary B Silberstein

Breast Cancer Res. 2005; 7(6): 245–251. Published online 2005 October 3. doi: 10.1186/bcr1331

PMCID:: PMC1410762

Abstract Full Text PDF–831K

Overdiagnosis and overtreatment of breast cancer: Estimates of overdiagnosis from two trials of mammographic screening for breast cancer

Stephen W Duffy, Olorunsola Agbaje, Laszlo Tabar, Bedrich Vitak, Nils Bjurstam, Lena Björneld, Jonathan P Myles, Jane Warwick

Breast Cancer Res. 2005; 7(6): 258–265. Published online 2005 November 10. doi: 10.1186/bcr1354

PMCID:: PMC1410738

Abstract Full Text PDF–754K

Overdiagnosis and overtreatment of breast cancer: Overdiagnosis and overtreatment in service screening

Eugenio Paci, Stephen Duffy

Breast Cancer Res. 2005; 7(6): 266–270. Published online 2005 November 10. doi: 10.1186/bcr1339

PMCID:: PMC1410748

Abstract Full Text PDF–54K

Overdiagnosis and overtreatment of breast cancer: Rates of ductal carcinoma in situ: a US perspective

Anjali S Kumar, Vinona Bhatia, I Craig Henderson

Breast Cancer Res. 2005; 7(6): 271–275. Published online 2005 November 11. doi: 10.1186/bcr1346

PMCID:: PMC1410763

Abstract Full Text PDF–163K

Imaging in breast cancer: Diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy

Bruce J Tromberg, Albert Cerussi, Natasha Shah, Montana Compton, Amanda Durkin, David Hsiang, John Butler, Rita Mehta

Breast Cancer Res. 2005; 7(6): 279–285. Published online 2005 November 28. doi: 10.1186/bcr1358

PMCID:: PMC1410753

Abstract Full Text PDF–804K

Editorial

Imaging in breast cancer – breast cancer imaging revisited

David Mankoff

Breast Cancer Res. 2005; 7(6): 276–278. Published online 2005 November 29. doi: 10.1186/bcr1359

PMCID:: PMC1410756

Full Text PDF–33K

Articles from Breast Cancer Research : BCR are provided here courtesy of
BioMed Central

PMC Canada | Copyright | Disclaimer

PubMed Central Canada is a service of the Canadian Institutes of Health Research (CIHR) working in partnership with the National Research Council's Canada Institute for Scientific and Technical Information in cooperation with the National Center for Biotechnology Information at the U.S. National Library of Medicine(NCBI/NLM). It includes content provided to the PubMed Central International archive by participating publishers.